Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
Assistance from government and private organizations, rising number of entities conducting research and declining cost of DNA sequencing and synthesizing are key driving factors of the market. Governments are providing funds to research organizations, assisting them to find novel applications of synthetic biology. Bio-safety & bio-security issues, ethical issues and regulations are key retraining factors of the market. The fact that synthetic biology can be misused has raised concerns all around the world. Further, there are possibilities of accidental release of pathogens or genetically modified organisms into free atmosphere.
Synthetic Biology Product Market Analysis
Synthetic Biology product market is segmented into enabling products, enabled products and core products. In 2013, enabled product segment was the largest revenue generating segment and this segment would not experience substantial market change in the coming years. Enabling product is the fastest growing segment at a CAGR of 53.7% during the forecast period. Enabling products have many applications in various fields. Advancement in the technologies require lot of issues to be addressed such as high rate of error in the self-assembly, high cost of DNA, etc. Use of enabling products can overcome these hurdles. This factor is triggering the growth of enabling products.
Synthetic Biology Technology Market Analysis
Synthetic Biology technology market is segmented into enabling technology and enabled technology. In 2013, enabled technology had generated highest revenue and it is forecast that in the coming years, this segment would continue to dominate the other segment in revenue generation. Enabling technologies segment is growing at a faster rate, and growing at a CAGR of 48.6% during the forecast period. Recent advancement in the cellular and molecular biology requires monitoring and manipulation of biological system. Use of enabling technologies results in applying engineering principles to build, manufacture, and design new biological devices and systems. This factor is triggering the growth of enabling technologies.
Synthetic Biology Application Market Analysis
Synthetic Biology application market is segmented into research & development, chemicals, agriculture, pharmaceuticals & diagnostics, biofuels and others (biotechnology and biomaterials). In 2013, pharmaceuticals & diagnostics was the largest revenue-generating segment and it is forecast that this segment would continue to dominate the other segments in revenue generation. Biofuels is the fastest growing segment at a CAGR of 85.2% during the forecast period. There is high demand for energy security, food safety and fuel generated from agriculture, which is contributing to the growth of the Biofuels market.
Synthetic Biology Geography Market Analysis
Synthetic Biology geography market is segmented into North America, Europe, Asia Pacific and RoW. In 2013, Europe was the largest revenue-generating segment and it is forecast that it would continue to dominate the other segment in generating revenue. In Europe, there were many supporting government regulations due to which it was possible to invest a lot in the synthetic biology research. These researches resulted into application of synthetic biology in various fields such as medicine, energy, environment, biological nanomachines & biosensors, chemical industry, national security. Asia- pacific is the fastest growing segment experiencing a CAGR of 46.4% during the forecast period. Asia pacific brings lot of opportunities for the growth of the Synthetic Biology market. The factors that are driving the growth of the market are large number of under nutrition population that brings in the need for increased food production. This factor results in high demand for synthetically modified crops. Rising petroleum based fuel prices are resulting in high demand for bio-diesel, which is also contributing to the growth of the synthetic biology market. In addition, raised awareness about synthetic biology market such as generation of new life, manipulation of life, etc., are also some of the factors that are unlocking the doors for the growth of the market.
Synthetic Biology Market Competitive Analysis
The strategies followed by key players in this market present a clear understanding about the intensity of concentration they are giving to a specific business segment. Strategic analysis of the companies reveals that most of the companies are concentrating on agreements followed by product launch for the expansion of their business. The agreements among the companies would enhance their operations and services. Most of the agreements were related to development of product for chemical industries, followed biofuels and synthetic genes industries. Product launches were adopted by the companies to diversify their products and explore new areas of applications. Companies adopted strategies to launch new products to diversify its approach in the chemical industry and pharmaceuticals. Companies also adopted strategies such as collaboration, joint venture and acquisition for the expansion of their business. These strategies resulted in the advancement of the technology and diversification of the products in the untapped areas. These strategies were adopted by the companies to diversify their business in the industries such as pharmaceuticals, synthetic genes, biofuels and chemicals.
Synthetic Biology Market High-Level Analysis
Porter’s five-force analysis weighs the bargaining power of buyers and suppliers including the rivalry scenario in the market. As far as core products of the market are concerned, there are few suppliers; and this fact raises the bargaining power of the suppliers. However, declining prices of DNA sequencing and synthesis may lower their bargaining power in future. Being a novel field, threat of substitute is low, as it is far better than the conventional technologies. The value chain analysis reveals that enabling products such as DNA synthesis and oligonucleotide synthesis act as building blocks for the core products and the core products are used by various industries to manufacture enabled products such as chemicals and bio-fuels. Top investment pocket analysis reveals biofuels as the most promising sector for investments in future. This market possesses huge growth potential; however, cash flow in this sector at present is comparatively low. Various petroleum and chemical companies are expected to enter this market during the forecast period.
- Analysis of the synthetic biology market on the basis of various segments such as products, technology, application and geography is expounded in the report.
- To study the various factors that are enhancing and restraining the growth of the market that would help the market players in deeply understanding the market
- Qualitative as well as quantitative analysis of the current market conditions coupled with future estimations through 2014-2020 would help stakeholders take strategic and profitable decisions
- Geographic analysis of the market would help the companies to plan and take region based decisions
- Porter’s five forces model helps to understand the bargaining power of buyers and suppliers and threat of the new entrants
- Analysis of the captivating strategies adopted by the market players is conducted and that would assist the stakeholders to take actionable decisions
- The analysis focuses on the wide variety of opportunities for the growth and expansion of the market
Reason for doing the study
Synthetic Biology is a relatively newer field, came into existence a decade ago. Many of its applications have recently entered the commercial market. Other potential applications would see commercialization in near future. As the market holds huge potential in future and has widespread applications, namely in industries such as chemical, pharmaceuticals, fuels, agricultural, healthcare, etc., the understanding of the market beforehand will give an upper hand to the stakeholders.
Market by Products
- Enabling Products
- DNA Synthesis
- Oligonucleotide Synthesis
- Enabled Products
- Core Products
- Synthetic DNA
- Synthetic Genes
- Synthetic Cells
- Chassis Organisms
Market by Technology
- Enabling Technology
- Genome Engineering
- Microfluidics technologies
- DNA synthesis & sequencing technologies
- Bioinformatics technologies
- Biological components and integrated systems technologies
- Enabled Technology
- Pathway engineering
- Synthetic microbial consortia
- Biofuels technologies
Market by Application
- Research & Development
- Pharmaceuticals & Diagnostics
- Others (Environment, Biotechnology & Biomaterials, etc.)
Market by Geography
- North America
- Asia Pacific
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key Benefits
1.3 Reason for doing the study
1.4 Key Market Segments
1.5 Research Methodology
1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Segment Analysis
2.2 Market beyond: what to expect by 2025
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top Factors Impacting synthetic biology market
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porters five force analysis
3.3.1 Fewer suppliers lead to higher bargaining power of suppliers
3.3.2 High demand leads to low buyer power
3.3.3 Innovative technology leads to low threat of substitute
3.3.4 Diverse application raises threat of new entrants
3.3.5 Competitive rivalry to be maintained due high exit barriers
3.4 Value chain analysis
3.4.4 Applications area
3.5 Policies and regulations
3.6 Concerns raised by synthetic biology
3.7 Case Studies
3.7.1 Case Study 1: Sourcing of fragrance from cured seed pod of vanilla orchid
3.7.2 Case Study 2: Trial of new synthetic biology technique to boost biodiesel production
3.7.3 Case Study 3: Potential impacts of synthetic biology on economy and livelihood
3.8 Market Dynamics (Synthetic Biology as a whole)
18.104.22.168 Funding and Assistance from government and private organizations
22.214.171.124 Rising number of entities conducting research
126.96.36.199 Rising number of companies entering the market
188.8.131.52 Declining cost of DNA Sequencing
184.108.40.206 Bio-safety and Bio-security Issues
220.127.116.11 Ethical challenges and formation of strict regulatory bodies
18.104.22.168 rising demand for bio-fuels
22.214.171.124 Rising economies of Asia Pacific
126.96.36.199 Increasing investments of WHO and other NGOs in developing countries
CHAPTER 4 OVERVIEW OF DNA SYNTHESIS
4.1 Technological trends in DNA synthesis
4.2 Commercial application scope for large DNA constructs in Europe and North America
4.2.1 Antibody engineering
4.2.2 Metabolic engineering
4.2.3 Pathway engineering
4.2.4 Other potential application (as a core products)
4.3 Top players positing, 2013, (Focus on DNA Synthesis)
4.4 Market Dynamics specific to DNA synthesis
188.8.131.52 Technical advancements of integrated sequencing
184.108.40.206 Growing demand for large DNA constructs
220.127.116.11 Increasing accountability of government funding
18.104.22.168 High cost and longer duration of DNA synthesis
22.214.171.124 Absence of regulatory guidelines
126.96.36.199 Exploring opportunities in European countries
CHAPTER 5 GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT
5.1 Global synthetic biology market by product
5.2 Enabling Products
5.2.1 Global synthetic biology market by enabling products
5.2.2 DNA synthesis
188.8.131.52 synthetic biology DNA Synthesis market by Geography
5.2.3 Oligonucleotide synthesis
184.108.40.206 synthetic biology Oligonucleotide Synthesis market by Geography
5.3 Core Products
5.3.1 Global synthetic biology market by core products
5.3.2 Synthetic DNA
220.127.116.11 synthetic biology Synthetic DNA market by Geography
5.3.3 Synthetic Genes
18.104.22.168 Global synthetic biology Synthetic genes market by geography
5.3.4 Synthetic Cells
22.214.171.124 synthetic biology Synthetic cells market by Geography
5.3.5 XNA (Xeno Nucleic Acid)
126.96.36.199 synthetic biology xna market by geography
5.3.6 Chassis Organisms
188.8.131.52 SYNTHETIC biology Chassis organisms market by Geography
5.4 Enabled Products
5.4.1 Global synthetic biology market by enabled products
5.4.2 Pharmaceuticals and Diagnostics
184.108.40.206 synthetic biology Pharmaceuticals and diagnostics market by geography
220.127.116.11 synthetic biology chemicals market by geography
18.104.22.168 synthetic biology biofuels market by geography
22.214.171.124 synthetic biology agriculture market by Geography
CHAPTER 6 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES
6.1 Global synthetic biology market by technologies
6.2 Enabling technologies
6.2.1 Global synthetic biology enabling technologies market by type
6.2.2 Genome Engineering
126.96.36.199 synthetic biology genome engineering market by Geography
6.2.3 Microfluidics technologies
188.8.131.52 synthetic biology Microfluidics technologies market by geography
184.108.40.206 DNA Microarrays - Oligo Synthesis
6.2.4 DNA Synthesis and sequencing
220.127.116.11 synthetic biology DNA Synthesis and sequencing market by geography
18.104.22.168 DNA synthesis technologies
22.214.171.124 DNA sequencing technologies
6.2.5 Bioinformatics technologies
126.96.36.199 synthetic biology bioinformatics technologies market by Geography
6.2.6 Biological components and integrated systems technologies
188.8.131.52 synthetic biology biological components and integrated systems technologies market by Geography
184.108.40.206 Synthetic genes
220.127.116.11 Biobrick parts
18.104.22.168 Minimal genomes and chassis organisms
6.3 Enabled Technologies
6.3.1 Global synthetic biology market by enabled technologies
6.3.2 Pathway engineering
22.214.171.124 Synthetic biology pathway engineering market by geography
6.3.3 Synthetic microbial consortia
126.96.36.199 synthetic biology synthetic microbial consortia market by geography
6.3.4 Biofuels technologies
188.8.131.52 synthetic biology biofuel technologies market by geography
CHAPTER 7 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION
7.1 Global synthetic biology market by application
7.2 Research & Development
7.2.1 Synthetic biology research & development market by geography
7.3 Chemicals industry
7.3.1 Synthetic biology chemical industry market by geography
7.4.1 Synthetic biology agriculture market by geography
7.5 Pharmaceuticals & diagnostics
7.5.1 Synthetic biology pharmaceuticals & diagnostics market by geography
7.6 Biofuels industry
7.6.1 Synthetic biology biofuels market by geography
7.7 Others (biotechnology, environment, biomaterials and so on)
7.7.1 Synthetic biology other applications market by geography
CHAPTER 8 SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY
8.1 North America
8.1.1 North America synthetic biology market
8.2.1 European Synthetic biology market
8.3 Asia Pacific
8.3.1 Asia Pacific synthetic biology market by application
8.4.1 RoW synthetic biology market by application
CHAPTER 9 COMPANY PROFILES
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business Performance
9.1.4 Strategic moves and developments
184.108.40.206 Principal Strategies: Agreements
9.1.5 Swot analysis of BASF
9.2 GEN9 Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business Performance
9.2.4 Strategic moves and developments
220.127.116.11 Principal Strategies: Product LAunches
9.2.5 Swot analysis of Gen9 Inc.
9.3 Algenol Biofuels
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business Performance
9.3.4 Strategic moves and developments
18.104.22.168 Principal Strategies: Agreements
9.3.5 Swot analysis of Algenol Biofuels
9.4 Codexis Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business Performance
9.4.4 Strategic moves and developments
22.214.171.124 Principal Strategies: Agreements
126.96.36.199 Secondary strategies: Product launch
9.4.5 Swot analysis of Codexis
9.5 GenScript Corporation
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business Performance
9.5.4 Strategic moves and developments
188.8.131.52 Principal Strategies: Product Launch
184.108.40.206 Secondary Strategies: Agreements
9.5.5 Swot analysis of GenScript
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments
220.127.116.11 Principal Strategies: Agreements
9.6.5 Swot analysis of DuPont
9.7 Butamax Advanced Biofuels
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments
18.104.22.168 Principal Strategies: Agreements
9.7.4 Swot analysis of Butamax Advanced Biofuels
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business Performance
9.8.4 Strategic moves and developments
22.214.171.124 Principal Strategies: Partnership
9.8.5 Swot analysis of BioAmber
9.9 Biosearch Technologies, Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments
126.96.36.199 Principal Strategies: Acquisition
188.8.131.52 Secondary strategies: Agreement & Product launch
9.9.4 Swot analysis of Biosearch
9.10 OriGene Technologies, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Strategic moves and developments
184.108.40.206 Principal Strategies: Acquisition
220.127.116.11 Secondary strategies: Product launch
9.10.4 Swot analysis of OriGene
9.11 Synthetic Genomics, Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Strategic moves and developments
18.104.22.168 Principal Strategies: Agreements
22.214.171.124 Secondary strategies: Collaboration
9.11.4 Swot analysis of Synthetic Genomics
9.12 GeneArt (Life Technologies)
9.12.2 Service portfolio of GeneArt (Life Technologies)
9.12.3 Key strategies
9.12.4 SWOT analysis of GeneArt (Life Technologies)
9.13 GENEWIZ, Inc.
9.13.1 Company overview
9.13.2 Services Portfolio
9.13.3 SWOT analysis of GENEWIZ, Inc.
9.14 Eurofins Scientific, Inc.
9.14.1 Company overview
9.14.2 Services portfolio
9.14.3 Strategic moves and developments
126.96.36.199 Principal Strategies
9.14.4 SWOT analysis of Eurofins Scientific, Inc.
9.15 Integrated DNA Technologies, Inc.
9.15.1 Company overview
9.15.2 Services Portfolio
9.15.3 Strategic moves and developments
188.8.131.52 Principal Strategies
184.108.40.206 Secondary Strategies
9.15.4 SWOT analysis of Integrated DNA Technologies, Inc.
9.16 DNA2.0, Inc.
9.16.1 Company overview
9.16.2 Services portfolio
9.16.3 Strategic moves and developments
220.127.116.11 Principal Strategies
18.104.22.168 Secondary Strategies
9.16.4 SWOT analysis of DNA2.0, Inc.
9.17 Pareto Biotechnologies
9.17.1 Company overview
9.17.2 Services Portfolio
9.17.3 Strategic moves and developments
22.214.171.124 Principal Strategies
126.96.36.199 Secondary Strategies
9.17.4 SWOT analysis of Parento Biotechnologies
9.18 Synthorx, Inc.
9.18.1 Company overview
9.18.2 Services Portfolio
9.18.3 SWOT analysis of Synthorx, Inc.
9.19 TeselaGen Biotechnology
9.19.1 Company overview
9.19.2 Services Portfolio
9.19.3 Strategic moves and developments
188.8.131.52 Principal Strategy
184.108.40.206 Secondary Strategy
9.19.4 SWOT Analysis of TeselaGen Biotechnology.
9.20 Editas Medicine, Inc.
9.20.1 Company overview
9.20.2 Services Portfolio
9.20.3 Strategic moves and development
220.127.116.11 Principal Strategy
18.104.22.168 Secondary Strategy
9.20.4 SWOT analysis of Editas Medicine, Inc.
9.21 Twist Bioscience
9.21.1 Company overview
9.21.2 Services portfolio
9.21.3 Strategic moves and developments
22.214.171.124 Principle Strategy
9.21.4 SWOT analysis of Twist Bioscience
9.22 GeneWorks Pty Ltd.
9.22.1 Company overview
9.22.2 Services portfolio
9.22.3 SWOT analysis of GeneWorks Pty. Ltd.
9.23 Proterro, Inc.
9.23.1 Company overview
9.23.2 Services portfolio
9.23.3 Strategic moves and developments
126.96.36.199 Principle Strategy
9.23.4 SWOT analysis of Proterro, Inc.
9.24 Blue heron (OriGene technologies Inc.)
9.24.2 Service portfolio of Blue heron (OriGene technologies Inc.)
9.24.3 SWOT analysis of Blue heron (OriGene technologies Inc.)
LIST OF TABLES
TABLE 1 SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 2 SYNTHETIC BIOLOGY MARKET MODERATE GROWTH SCENARIO BY GEOGRAPHY, BASE CASE, 2020 - 2025 ($MILLION)
TABLE 3 SYNTHETIC BIOLOGY MARKET RAPID GROWTH SCENARIO BY GEOGRAPHY, 2020 - 2025 ($MILLION)
TABLE 4 NORTH AMERICA SYNTHETIC BIOLOGY MARKET DIMINISHING GROWTH SCENARIO BY GEOGRAPHY, 2020 - 2025 ($MILLION)
TABLE 5 COMMERCIAL APPLICATION OF SYNTHETIC BIOLOGY IN DERIVING RENEWABLE ENERGY
TABLE 6 GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT, 2013 - 2020 ($MILLION)
TABLE 7 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLING PRODUCTS, 2013 - 2020 ($MILLION)
TABLE 8 SYNTHETIC BIOLOGY DNA SYNTHESIS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 9 GLOBAL SYNTHETIC BIOLOGY MARKET BY OLIGONUCLEOTIDE SYNTHESIS, 2013 - 2020 ($MILLION)
TABLE 10 GLOBAL SYNTHETIC BIOLOGY MARKET BY CORE PRODUCTS, 2013 - 2020 ($MILLION)
TABLE 11 SYNTHETIC BIOLOGY SYNTHETIC DNA MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 12 GLOBAL SYNTHETIC BIOLOGY MARKET BY SYNTHETIC GENES, 2013 - 2020 ($MILLION)
TABLE 13 GLOBAL SYNTHETIC BIOLOGY SYNTHETIC CELLS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 14 GLOBAL SYNTHETIC BIOLOGY MARKET BY XNA, 2013 - 2020 ($MILLION)
TABLE 15 SYNTHETIC BIOLOGY CHASSIS ORGANISMS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 16 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED PRODUCTS, 2013 - 2020 ($MILLION)
TABLE 17 SYNTHETIC BIOLOGY PHARMACEUTICALS AND DIAGNOSTICS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 18 SYNTHETIC BIOLOGY CHEMICALS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 19 SYNTHETIC BIOLOGY BIOFUELS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 20 SYNTHETIC BIOLOGY AGRICULTURE MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 21 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGIES, 2013 - 2020 ($MILLION)
TABLE 22 GLOBAL SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET BY TYPE, 2013 - 2020 ($MILLION)
TABLE 23 SYNTHETIC BIOLOGY GENOME ENGINEERING MARKET BY GEOGRAPHY 2013 - 2020 ($MILLION)
TABLE 24 SYNTHETIC BIOLOGY MICROFLUIDICS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 25 SYNTHETIC BIOLOGY DNA SYNTHESIS AND SEQUENCING MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 26 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 27 SYNTHETIC BIOLOGY BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 28 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED TECHNOLOGIES, 2013 - 2020 ($MILLION)
TABLE 29 SYNTHETIC BIOLOGY PATHWAY ENGINEERING MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 30 SYNTHETIC BIOLOGY SYNTHETIC MICROBIAL CONSORTIA MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 31 GLOBAL SYNTHETIC BIOLOGY MARKET BY BIOFUEL TECHNOLOGIES, 2013 - 2020 ($MILLION)
TABLE 32 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 33 GLOBAL SYNTHETIC BIOLOGY MARKET BY RESEARCH AND DEVELOPMENT, 2013 - 2020 ($MILLION)
TABLE 34 SYNTHETIC BIOLOGY CHEMICAL INDUSTRY MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 35 SYNTHETIC BIOLOGY AGRICULTURE MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 36 SYNTHETIC BIOLOGY PHARMACEUTICALS & DIAGNOSTICS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 37 SYNTHETIC BIOLOGY BIOFUELS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 38 SYNTHETIC BIOLOGY OTHER APPLICATIONS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
TABLE 39 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 40 EUROPE SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 41 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 42 ROW SYNTHETIC BIOLOGY MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
TABLE 43 BASF SNAPSHOT
TABLE 44 BUSINESS REVENUES BY SECTORS (2013)
TABLE 45 GEN9INC. SNAPSHOT
TABLE 46 ALGENOL SNAPSHOT
TABLE 47 CODEXIS SNAPSHOT
TABLE 48 GENSCRIPT SNAPSHOT
TABLE 49 DUPONT SNAPSHOT
TABLE 50 BUTAMAX ADVANCED BIOFUELS
TABLE 51 BIOAMBER SNAPSHOT
TABLE 52 BIOSEARCH SNAPSHOT
TABLE 53 ORIGENE SNAPSHOT
TABLE 54 SYNTHETIC GENOMICS SNAPSHOT
TABLE 55 COMPANY SNAPSHOT OF GENEART (LIFE TECHNOLOGIES)
TABLE 56 SERVICE PORTFOLIO OF GENEART AG (LIFE TECHNOLOGIES)
TABLE 57 COMPANY SNAPSHOT OF GENEWIZ, INC.
TABLE 58 SERVICES PORTFOLIO OF GENEWIZ, INC
TABLE 59 COMPANY SNAPSHOT OF EUROFINS SCIENTIFIC, INC.
TABLE 60 SERVICE PORTFOLIO OF EUROFINS SCIENTIFIC,INC.
TABLE 61 COMPANY SNAPSHOT OF INTEGRATED DNA TECHNOLOGIES, INC
TABLE 62 SERVICES PORTFOLIO OF INTEGRATED DNA TECHNOLOGIES, INC.
TABLE 63 COMPANY SNAPSHOT OF DNA2.0, INC.
TABLE 64 SERVICES PORTFOLIO OF DNA2.0, INC.
TABLE 65 COMPANY SNAPSHOT OF PARENTO BIOTECHNOLOGIES
TABLE 66 SERVICES PORTFOLIO OF PARENTO BIOTECHNOLOGIES
TABLE 67 COMPANY SNAPSHOT OF SYNTHORX, INC.
TABLE 68 SERVICES PORTFOLIO OF SYNTHORX, INC.
TABLE 69 COMPANY SNAPSHOT OF TESELAGEN BIOTECHNOLOGY
TABLE 70 SERVICES PORTFOLIO OF TESELAGEN BIOTECHNOLOGY
TABLE 71 COMPANY SNAPSHOT OF EDITAS MEDICINE, INC.
TABLE 72 SERVICES PORTFOLIO OF EDITAS MEDICINE, INC.
TABLE 73 COMPANY SNAPSHOT OF TWIST BIOSCIENCE
TABLE 74 SERVICES PORTFOLIO OF TWIST BIOSCIENCE
TABLE 75 COMPANY SNAPSHOT OF GENEWORKS PTY. LTD.
TABLE 76 SERVICES PORTFOLIO OF GENEWORKS PTY. LTD.
TABLE 77 COMPANY SNAPSHOT OF PROTERRO, INC.
TABLE 78 SERVICES PORTFOLIO OF PROTERRO, INC.
TABLE 79 COMPANY SNAPSHOT OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)
TABLE 80 SERVICE PORTFOLIO OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)
LIST OF FIGURES
FIG. 1 TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (2020 - 2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020 - 2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020 - 2025)
FIG. 4 TOP FACTORS IMPACTING MARKET SYNTHETIC BIOLOGY MARKET
FIG. 5 TOP INVESTMENT POCKETS IN SYNTHETIC BIOLOGY APPLICATION MARKET
FIG. 6 TOP WINNING STRATEGIES FOLLOWED BY KEY PLAYERS (2011-2014)
FIG. 7 PORTERS FIVE FORCE ANALYSIS
FIG. 8 VALUE CHAIN ANALYSIS
FIG. 9 WORLDWIDE MAJOR ENTITIES CONDUCTING RESEARCH IN SYNTHETIC BIOLOGY (2009-2013)
FIG. 10 TOP PLAYERS POSITING OF SYNTHETIC BIOLOGY MARKET (2013)
FIG. 11 COST PER RAW MEGABASE OF DNA SEQUENCE
FIG. 12 WORLD BIODIESEL PRODUCTION AND CAPACITY
FIG. 13 NUMBER OF ENTITIES CONDUCTING RESEARCH IN STATES OF THE U.S.
FIG. 14 BIOFUEL PRODUCTION BY MAJOR REGIONS (2011 - 2020)
FIG. 15 MAJOR ENTITIES CONDUCTING RESEARCH IN THE U.S.
FIG. 16 MAJOR ENTITIES CONDUCTING RESEARCH IN EUROPE
FIG. 17 TOP SUGAR EXPORTERS 2012 (MILLION TONS)
FIG. 18 FINANCIAL REVENUES BY GEOGRAPHY (2013)
FIG. 19 SWOT ANALYSIS OF BASF
FIG. 20 SWOT ANALYSIS OF GEN9INC.
FIG. 21 SWOT ANALYSIS OF ALGENOL BIOFUELS
FIG. 22 SWOT ANALYSIS OF CODEXIS
FIG. 23 SWOT ANALYSIS OF GENSCRIPT
FIG. 24 SALES BY SEGMENTS (2013)
FIG. 25 SALES BY REGION (2013)
FIG. 26 SWOT ANALYSIS OF DUPONT
FIG. 27 SWOT ANALYSIS OF BUTAMAX ADVANCED BIOFUELS
FIG. 28 SWOT ANALYSIS OF BIOAMBER
FIG. 29 SWOT ANALYSIS OF BIOSEARCH
FIG. 30 SWOT ANALYSIS OF BIOSEARCH
FIG. 31 SWOT ANALYSIS OF SYNTHETIC GENOMICS
FIG. 32 SWOT ANALYSIS OF GENEART (LIFE TECHNOLOGIES)
FIG. 33 SWOT ANALYSIS OF GENEWIZ, INC.
FIG. 34 SWOT ANALYSIS OF EUROFINS SCIENTIFIC, INC.
FIG. 35 SWOT ANALYSIS OF INTEGRATED DNA TECHNOLOGIES, INC.
FIG. 36 SWOT ANALYSIS OF DNA2.0, INC.
FIG. 37 SWOT ANALYSIS OF PARENTO BIOTECHNOLOGIES
FIG. 38 SWOT ANALYSIS OF SYNTHORX, INC.
FIG. 39 SWOT ANALYSIS OF TESELAGEN BIOTECHNOLOGY.
FIG. 40 SWOT ANALYSIS OF EDITAS MEDICINE, INC.
FIG. 41 SWOT ANALYSIS OF TWIST BIOSCIENCE
FIG. 42 SWOT ANALYSIS OF GENEWORKS PTT. LTD.
FIG. 43 SWOT ANALYSIS OF PROTERRO, INC.
FIG. 44 SWOT ANALYSIS OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)